Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation.
|
31456217 |
2020 |
Glioblastoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Here, we find that the chromatin regulator, JmjC domain histone H3K36me2/me1 demethylase KDM2B, is highly expressed in glioblastoma surgical specimens compared to normal brain.
|
29360266 |
2018 |
Glioblastoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.
|
30087349 |
2018 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
As the first identified messenger RNA <i>N</i><sup>6</sup>-methyladenosine (m<sup>6</sup>A) demethylase, FTO has been shown recently to play m<sup>6</sup>A-dependent roles in adipogenesis and tumorigenesis (especially in the development of leukemia and glioblastoma).
|
30105001 |
2018 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
ALKBH5 (another m<sup>6</sup>A demethylase) has been reported to exert a tumor-promoting function in glioblastoma and breast cancer.
|
29040886 |
2018 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.
|
28384648 |
2017 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.
|
28432280 |
2017 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
|
27367247 |
2017 |
Glioblastoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Slow-cycling cells with high Notch activity and histone demethylase expression are present in primary glioblastomas before treatment, potentially contributing to relapse.
|
27989769 |
2017 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here, we show that oncogenic epidermal growth factor receptor (EGFR) induces silencing of multiple unrelated tumor suppressors in lung adenocarcinomas and glioblastomas by inhibiting the DNA demethylase TET oncogene family member 1 (TET1) via the C/EBPα transcription factor.
|
27346347 |
2016 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
|
26566863 |
2015 |
Glioblastoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms.
|
23236496 |
2012 |
Glioblastoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.
|
21724586 |
2011 |